Thus, the current study confirmed that improvement of CD risk prediction sensitivity could be achieved by including the rs3130484 SNP of the MSH5 gene to the celiac-specific HLA haplotypes in genetic testing. This evidence concerns the gene MSH5 and Cowden disease.